Proteomic Approaches to Defining Remission and the Risk of Relapse in Rheumatoid Arthritis

Proteomic Approaches to Defining Remission and the Risk of Relapse in Rheumatoid Arthritis

ObjectivesPatients with Rheumatoid Arthritis (RA) are increasingly achieving stable disease remission, yet the mechanisms that govern ongoing clinical disease and subsequent risk of future flare are not well understood. We sought to identify serum proteomic alterations that dictate clinically import...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Liam J. O’Neil, Pingzhao Hu, Qian Liu, Md. Mohaiminul Islam, Victor Spicer, Juergen Rech, Axel Hueber, Vidyanand Anaparti, Irene Smolik, Hani S. El-Gabalawy, Georg Schett, John A. Wilkins
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
rheumatoid arthritis
disease activity
outcomes research
treatment
proteomics
Immunologic diseases. Allergy
RC581-607
Acceso en línea:https://doaj.org/article/cf6534dc36e54628942187bed207ce42
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares